Founded in Switzerland in November 2012, ObsEva is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy.
ObsEva is led by a strong management team with substantial experience in successfully developing and commercializing pharmaceutical products in our target market. ObsEva’s team members include trained obstetricians and gynecologists with an in-depth understanding of patient and physician needs. Our expertise has led to the development of new and innovative therapies that have the potential to improve patient outcomes in reproductive health.Latest Company Investor presentation
Are you ready to join an innovative biopharmaceutical company that’s advancing women’s reproductive health and pregnancy therapeutics? Explore our available vacancies below.